Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (191-200 of 311) with videos related to

Pageof 32
Sort By:
International Journal of Cardiology|August 23, 2018
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018Horst Olschewski, Jürgen Behr, Hinrich Bremer, et al.
Journal of the American College of Cardiology|October 1, 2021
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial HypertensionKelly M Chin, Olivier Sitbon, Martin Doelberg, et al.
Circulation|April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial HypertensionKelly M Chin, Lewis J Rubin, Richard Channick, et al.
The European Respiratory Journal|August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertensionSean Gaine, Kelly Chin, Gerry Coghlan, et al.
Cells|February 25, 2022
Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary SarcoidosisJan C Kamp, Lavinia Neubert, Helge Stark, et al.
JACC. Advances|February 25, 2025
Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart DiseaseRichard A Krasuski, Tobore Tobore, Sean Studer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 26, 2019
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trialVallerie V McLaughlin, Jean-Luc Vachiery, Ronald J Oudiz, et al.
Journal of the American College of Cardiology|June 25, 2003
Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31Matthias Rindermann, Ekkehard Grünig, Albrecht von Hippel, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 8, 2018
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON StudyJ Gerry Coghlan, Richard Channick, Kelly Chin, et al.
The European Respiratory Journal|November 13, 2012
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyStephanie Meyer, Vallerie V McLaughlin, Hans-Juergen Seyfarth, et al.
Pageof 32

Showing results (191-200 of 311) with videos related to

Sort By:
Pageof 32
International Journal of Cardiology|August 23, 2018
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018Horst Olschewski, Jürgen Behr, Hinrich Bremer, et al.
Journal of the American College of Cardiology|October 1, 2021
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial HypertensionKelly M Chin, Olivier Sitbon, Martin Doelberg, et al.
Circulation|April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial HypertensionKelly M Chin, Lewis J Rubin, Richard Channick, et al.
The European Respiratory Journal|August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertensionSean Gaine, Kelly Chin, Gerry Coghlan, et al.
Cells|February 25, 2022
Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary SarcoidosisJan C Kamp, Lavinia Neubert, Helge Stark, et al.
JACC. Advances|February 25, 2025
Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart DiseaseRichard A Krasuski, Tobore Tobore, Sean Studer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 26, 2019
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trialVallerie V McLaughlin, Jean-Luc Vachiery, Ronald J Oudiz, et al.
Journal of the American College of Cardiology|June 25, 2003
Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31Matthias Rindermann, Ekkehard Grünig, Albrecht von Hippel, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 8, 2018
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON StudyJ Gerry Coghlan, Richard Channick, Kelly Chin, et al.
The European Respiratory Journal|November 13, 2012
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyStephanie Meyer, Vallerie V McLaughlin, Hans-Juergen Seyfarth, et al.
Pageof 32